Research Subscription | Market Research Subscription Platform

Why PharmDelve?

Analyzing the future in the present

PharmDelve offers a right technology enabling clients to optimize their business goals and take time-critical decisions. Equipped with human as well as machine intelligence it is committed to transform data into comprehensive insights. Trusted CAGRs, 10 year forecasts, unrivaled coverage, KOL opinions and a dedicated team set us apart. Be it the existing drugs or the emerging ones, whether it’s a rare disease or the most prevalent ones, PharmDelve has covered it all. Committed to offer the best insights helping clients gain an edge.

Global Coverage

75%

Indication Coverage

85%

Top 500 Pharma Clients

60%

PharmDelve for relevant insights, intense analysis and eloquent reports.

What is PharmDelve?

PharmDelve is a tech driven, global business intelligence and market research repository. It is engrained with rich features aiming to revolutionize the way market reports are delivered and maneuvered.

Report Types

Market Insights

Market Insights offer an over-arching market research report with an in-depth analysis of a particular therapy area’s overall assessment in terms of market sales, epidemiology, market drivers & barriers, forecasted projections on market share and sizing.

Pipeline Insights

Pipeline Insights provides a detailed profile of all the clinical and non-clinical assets along with deals, collaborations, licensing and patent information. It also includes therapeutic assessment for all the active drugs based on molecule type, route, monotherapies and combination therapies.

Epidemiology Insights

Epidemiology Insights present a structure of Epidemiological Research and understanding of various indications listing its prevalence/incidence and distribution in different geographies, clinical manifestations, etiology, pathophysiology, severity, diagnosis and therapies.

Rare Insights

The data on rare diseases is much rare. The rare insights are curated with high quality primary analysis along with dedicated secondary amalysis. It’s there to help those companies which are committed to help a very few sufferers in the market. It includes but is not limited to epidemiology analysis and market analysis.

DelveInsight

Our Milestone and Roadmap



May 2019

Launched a revolutionary,
Tech oriented subscription platform, "PharmDelve".



Jan 2018

Portfolio Expansion Introduced new report - Launch Insight. Started with 8MM coverage.



Jan 2016

Launched a full-fledged report store containing 3000+ reports.
Started Partnering & Licensing.



Jan 2019

Anchored consulting, competitive intelligence and customized projects catering to 15+ MM.



July 2017

Global footprints (7MM).
Introduced Market Access, Asset
& Indication Prioritization.



Jan 2015

Systemized report portfolio.
Launched CI, Pipeline Insight, Drug Insight , API Insight reports.



Oct 2018

300+ Global clients.
Covered US, Europe & APAC.
Focus on customized projects



Jan 2017

200+ clients.
Market Insights & Epidemiology Insight became hot-selling reports of the industry.



Aug 2014

Launched pharmaceutical market research services . Introduced consulting service portfolio.



May 2018

Introduced reports focused exclusively on APAC region. Customized forecasting projects.



Aug 2016

100+ global Clients.
Introduced customizable reports.
Expanded Business Consulting portfolio.



Feb 2014

Laid the foundation with a team of pioneers from healthcare industry.

Flexible Packages

We offer handcrafted report packages keeping them completely custom-tailored for our clients. Be it the therapeutic based package or the report type based, they can be utilized by several users making it a versatile platform.

The packages are customized for each and everyone. If you are a pharmaceutical company or an individual, the subscriptions can be designed to serve you and your particular need.